Selective neuronal degeneration in Huntington's disease
- PMID: 16984809
- DOI: 10.1016/S0070-2153(06)75002-5
Selective neuronal degeneration in Huntington's disease
Abstract
Huntington's disease (HD) is a progressive neurodegenerative disorder that generally begins in middle age with abnormalities of movement, cognition, personality, and mood. Neuronal loss is most marked among the medium-sized projection neurons of the dorsal striatum. HD is an autosomal dominant genetic disorder caused by a CAG expansion in exon 1 of the HD gene, encoding an expanded polyglutamine (polyQ) tract near the N-terminus of the protein huntingtin. Despite identification of the gene mutation more than a decade ago, the normal function of this ubiquitously expressed protein is still under investigation and the mechanisms underlying selective neurodegeneration in HD remain poorly understood. Detailed postmortem analyses of brains of HD patients have provided important clues, and HD transgenic and knock-in mouse models have facilitated investigations into potential pathogenic mechanisms. Subcellular fractionation and immunolocalization studies suggest a role for huntingtin in organelle transport, protein trafficking, and regulation of energy metabolism. Consistent with this, evidence from vertebrate and invertebrate models of HD indicates that expression of the polyQ-expanded form of huntingtin results in early impairment of axonal transport and mitochondrial function. As well, alteration in activity of the N-methyl-d-aspartate (NMDA) type glutamate receptor, which has been implicated as a main mediator of excitotoxic neuronal death, especially in the striatum, is an early effect of mutant huntingtin. Proteolysis and nuclear localization of huntingtin also occur relatively early, while formation of ubiquitinated aggregates of huntingtin and transcriptional dysregulation occur as late effects of the gene mutation. Although each of these processes may contribute to neuronal loss in HD, here we review the data to support a strong role for NMDA receptor (NMDAR)-mediated excitotoxicity and mitochondrial dysfunction in conferring selective neuronal vulnerability in HD.
Similar articles
-
N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease.Prog Neurobiol. 2007 Apr;81(5-6):272-93. doi: 10.1016/j.pneurobio.2006.11.003. Epub 2006 Dec 22. Prog Neurobiol. 2007. PMID: 17188796 Review.
-
Excitotoxic neuronal death and the pathogenesis of Huntington's disease.Arch Med Res. 2008 Apr;39(3):265-76. doi: 10.1016/j.arcmed.2007.11.011. Arch Med Res. 2008. PMID: 18279698 Review.
-
Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons.J Neurochem. 2009 Oct;111(2):460-72. doi: 10.1111/j.1471-4159.2009.06344.x. Epub 2009 Aug 17. J Neurochem. 2009. PMID: 19686238
-
Neuronal vulnerability in mouse models of Huntington's disease: membrane channel protein changes.J Neurosci Res. 2005 Jun 1;80(5):634-45. doi: 10.1002/jnr.20492. J Neurosci Res. 2005. PMID: 15880743
-
Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease.Exp Neurol. 2010 Jul;224(1):155-62. doi: 10.1016/j.expneurol.2010.03.005. Epub 2010 Mar 19. Exp Neurol. 2010. PMID: 20227407
Cited by
-
Trichostatin A enhances glutamate transporter GLT-1 mRNA levels in C6 glioma cells via neurosteroid-mediated cell differentiation.J Mol Neurosci. 2013 Jan;49(1):21-7. doi: 10.1007/s12031-012-9842-1. Epub 2012 Jun 19. J Mol Neurosci. 2013. PMID: 22711563
-
Alterations of striatal glutamate transmission in rotenone-treated mice: MRI/MRS in vivo studies.Exp Neurol. 2008 Jan;209(1):224-33. doi: 10.1016/j.expneurol.2007.09.023. Epub 2007 Oct 4. Exp Neurol. 2008. PMID: 18028910 Free PMC article.
-
Current understanding on the pathogenesis of polyglutamine diseases.Neurosci Bull. 2010 Jun;26(3):247-56. doi: 10.1007/s12264-010-0113-2. Neurosci Bull. 2010. PMID: 20502504 Free PMC article. Review.
-
Nucleocytoplasmic Transport: Regulatory Mechanisms and the Implications in Neurodegeneration.Int J Mol Sci. 2021 Apr 17;22(8):4165. doi: 10.3390/ijms22084165. Int J Mol Sci. 2021. PMID: 33920577 Free PMC article. Review.
-
Translating cerebellar Purkinje neuron physiology to progress in dominantly inherited ataxia.Future Neurol. 2014 Mar 1;9(2):187-196. doi: 10.2217/fnl.14.6. Future Neurol. 2014. PMID: 25221437 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials